Published in Gut on January 01, 2005
Inherited determinants of Crohn's disease and ulcerative colitis phenotypes: a genetic association study. Lancet (2015) 2.74
Cancer surveillance in patients with primary sclerosing cholangitis. Hepatology (2011) 2.01
Extraintestinal manifestations in inflammatory bowel disease. World J Gastroenterol (2005) 1.82
Risk for colorectal cancer in ulcerative colitis: changes, causes and management strategies. World J Gastroenterol (2008) 1.79
Analysis of five chronic inflammatory diseases identifies 27 new associations and highlights disease-specific patterns at shared loci. Nat Genet (2016) 1.74
Pathogenesis of primary sclerosing cholangitis and advances in diagnosis and management. Gastroenterology (2013) 1.58
Diagnostic criteria for IgG4-related sclerosing cholangitis based on cholangiographic classification. J Gastroenterol (2011) 1.49
Diagnosis of IgG4-related sclerosing cholangitis. World J Gastroenterol (2013) 1.32
Primary sclerosing cholangitis, autoimmune hepatitis and overlap syndromes in inflammatory bowel disease. World J Gastroenterol (2008) 1.25
Current management of inflammatory bowel disease and colorectal cancer. Gastrointest Cancer Res (2011) 1.21
Extraintestinal Manifestations of Inflammatory Bowel Disease. Inflamm Bowel Dis (2015) 1.21
Extraintestinal manifestations and complications in IBD. Nat Rev Gastroenterol Hepatol (2013) 1.18
Colorectal cancer in inflammatory bowel disease: the risk, pathogenesis, prevention and diagnosis. World J Gastroenterol (2014) 1.16
The immunobiology of primary sclerosing cholangitis. Semin Immunopathol (2009) 1.15
Three ulcerative colitis susceptibility loci are associated with primary sclerosing cholangitis and indicate a role for IL2, REL, and CARD9. Hepatology (2011) 1.09
Primary sclerosing cholangitis: overview and update. Nat Rev Gastroenterol Hepatol (2010) 1.08
The diagnosis and treatment of Crohn's disease and ulcerative colitis. Dtsch Arztebl Int (2009) 1.07
Pathogenesis of primary sclerosing cholangitis. Best Pract Res Clin Gastroenterol (2011) 1.04
Extraintestinal manifestations of inflammatory bowel disease: do they influence treatment and outcome? World J Gastroenterol (2011) 1.03
Risk of ulcerative colitis-associated colorectal cancer in China: a multi-center retrospective study. Dig Dis Sci (2011) 1.00
Primary sclerosing cholangitis: diagnosis, prognosis, and management. Clin Gastroenterol Hepatol (2013) 0.98
Role of the microbiota and antibiotics in primary sclerosing cholangitis. Biomed Res Int (2013) 0.97
Disease activity and cancer risk in inflammatory bowel disease associated with primary sclerosing cholangitis. World J Gastroenterol (2008) 0.96
The impact of co-existing immune-mediated on phenotype and outcomes in inflammatory bowel diseases. Aliment Pharmacol Ther (2017) 0.96
Inflammatory bowel disease-associated colorectal cancer: proctocolectomy and mucosectomy do not necessarily eliminate pouch-related cancer incidences. Int J Colorectal Dis (2011) 0.95
Differential diagnosis in inflammatory bowel disease colitis: state of the art and future perspectives. World J Gastroenterol (2015) 0.95
Clinical features and management of primary sclerosing cholangitis. World J Gastroenterol (2008) 0.94
The role of the gut microbiota in NAFLD. Nat Rev Gastroenterol Hepatol (2016) 0.93
Epidemiology, demographic characteristics and prognostic predictors of ulcerative colitis. World J Gastroenterol (2014) 0.93
Lymphocyte recruitment and homing to the liver in primary biliary cirrhosis and primary sclerosing cholangitis. Semin Immunopathol (2009) 0.91
Mortality and extraintestinal cancers in patients with primary sclerosing cholangitis and inflammatory bowel disease. J Crohns Colitis (2014) 0.91
Distinctive inflammatory bowel disease phenotype in primary sclerosing cholangitis. World J Gastroenterol (2015) 0.90
Atypical distribution of inflammation in newly diagnosed ulcerative colitis is not rare. Can J Gastroenterol Hepatol (2014) 0.90
Genetic epidemiology of primary sclerosing cholangitis. World J Gastroenterol (2007) 0.90
The prevalence, incidence and natural history of primary sclerosing cholangitis in an ethnically diverse population. BMC Gastroenterol (2011) 0.88
Update on inflammatory bowel disease in patients with primary sclerosing cholangitis. World J Hepatol (2014) 0.88
Hepatobiliary manifestations of ulcerative colitis: an example of gut-liver crosstalk. Gastroenterol Rep (Oxf) (2014) 0.87
Primary sclerosing cholangitis. Orphanet J Rare Dis (2006) 0.87
Management of primary sclerosing cholangitis: conventions and controversies. Can J Gastroenterol (2012) 0.86
The microbiota regulates susceptibility to Fas-mediated acute hepatic injury. Lab Invest (2014) 0.85
Liver disorders in inflammatory bowel disease. Gastroenterol Res Pract (2012) 0.85
Comparison of outcomes for patients with primary sclerosing cholangitis associated with ulcerative colitis and Crohn's disease. Gastroenterol Rep (Oxf) (2014) 0.83
Hepatobiliary manifestations in inflammatory bowel disease: the gut, the drugs and the liver. World J Gastroenterol (2013) 0.82
Backwash ileitis and the risk of colon neoplasia in ulcerative colitis patients undergoing restorative proctocolectomy. Dig Dis Sci (2013) 0.82
Characterization of animal models for primary sclerosing cholangitis (PSC). J Hepatol (2014) 0.81
The phenotypic expression of inflammatory bowel disease in patients with primary sclerosing cholangitis differs in the distribution of colitis. Dig Dis Sci (2013) 0.81
Contrasting Pattern of Chronic Inflammatory Bowel Disease in Primary and Autoimmune Sclerosing Cholangitis. EBioMedicine (2015) 0.81
Autoantibodies in primary sclerosing cholangitis. World J Gastroenterol (2008) 0.81
Primary Sclerosing Cholangitis: Multiple Phenotypes, Multiple Approaches. Clin Liver Dis (2015) 0.80
Inflammatory bowel disease of primary sclerosing cholangitis: a distinct entity? World J Gastroenterol (2014) 0.80
Ulcerative colitis: a challenge to surgeons. Int J Prev Med (2012) 0.80
Impact of transjugular intrahepatic portosystemic shunt on post-colectomy complications in patients with ulcerative colitis and primary sclerosing cholangitis. Gastroenterol Rep (Oxf) (2014) 0.80
Analysis of mutations in TP53, APC, K-ras, and DCC genes in the non-dysplastic mucosa of patients with inflammatory bowel disease. Int J Colorectal Dis (2009) 0.80
A prospective analysis of clinical variables, serologic factors, and outcome of ileal pouch-anal anastomosis in patients with backwash ileitis. Dis Colon Rectum (2010) 0.79
The features of mucosa-associated microbiota in primary sclerosing cholangitis. Aliment Pharmacol Ther (2016) 0.79
Steroid-refractory ulcerative colitis and associated primary sclerosing cholangitis treated with infliximab. World J Gastroenterol (2013) 0.79
Risk and Surveillance of Cancers in Primary Biliary Tract Disease. Gastroenterol Res Pract (2016) 0.78
Primary Biliary Cirrhosis and Primary Sclerosing Cholangitis: a Review Featuring a Women's Health Perspective. J Clin Transl Hepatol (2014) 0.77
Inflammatory bowel disease in pediatric and adolescent patients: a biomolecular and histopathological review. World J Gastroenterol (2014) 0.77
Outcome of patients with primary sclerosing cholangitis and ulcerative colitis undergoing colectomy. World J Gastrointest Pharmacol Ther (2013) 0.77
Colitis-associated colon cancer: Is it in your genes? World J Gastroenterol (2015) 0.77
The effect of liver transplantation for primary sclerosing cholangitis on disease activity in patients with inflammatory bowel disease. Gastroenterol Hepatol (N Y) (2013) 0.77
Liver Expression of Sulphotransferase 2A1 Enzyme Is Impaired in Patients with Primary Sclerosing Cholangitis: Lack of the Response to Enhanced Expression of PXR. J Immunol Res (2015) 0.77
Dysregulated intrahepatic CD4(+) T-cell activation drives liver inflammation in ileitis-prone SAMP1/YitFc mice. Cell Mol Gastroenterol Hepatol (2015) 0.77
Solid Organ Transplantation in Patients with Inflammatory Bowel Diseases (IBD): Analysis of Transplantation Outcome and IBD Activity in a Large Single Center Cohort. PLoS One (2015) 0.76
Epithelial markers of colorectal carcinogenesis in ulcerative colitis and primary sclerosing cholangitis. World J Gastroenterol (2013) 0.76
The long-term outcomes of a cohort of Sri Lankan patients with ulcerative colitis: a retrospective study at two national referral centers and review of literature. Clin Exp Gastroenterol (2013) 0.76
Primary sclerosing cholangitis as an independent risk factor for colorectal cancer in the context of inflammatory bowel disease: a review of the literature. World J Gastroenterol (2014) 0.76
Clinical course and prognosis of pediatric-onset primary sclerosing cholangitis. United European Gastroenterol J (2015) 0.76
Controversies in the management of primary sclerosing cholangitis. World J Hepatol (2016) 0.76
The evolution of natural history of primary sclerosing cholangitis. Curr Opin Gastroenterol (2016) 0.75
Crohn's disease and solid organ transplantation. Gastroenterol Hepatol (N Y) (2008) 0.75
Celiac disease, enteropathy-associated T-cell lymphoma, and primary sclerosing cholangitis in one patient: a very rare association and review of the literature. Case Rep Oncol Med (2013) 0.75
A Review of Inflammatory Bowel Disease in the Setting of Liver Transplantation. Gastroenterol Hepatol (N Y) (2014) 0.75
Functional and protein‑protein interaction network analysis of colorectal cancer induced by ulcerative colitis. Mol Med Rep (2015) 0.75
Primary sclerosing cholangitis and the risk of colon neoplasia in patients with Crohn's colitis. Gastroenterol Rep (Oxf) (2015) 0.75
Pathogenesis and clinical spectrum of primary sclerosing cholangitis. World J Gastroenterol (2017) 0.75
IBD: A timely diagnosis of primary sclerosing cholangitis in IBD. Nat Rev Gastroenterol Hepatol (2016) 0.75
Genetics of primary sclerosing cholangitis and pathophysiological implications. Nat Rev Gastroenterol Hepatol (2017) 0.75
Primary Sclerosing Cholangitis: Current and Future Management Strategies. Curr Hepat Rep (2013) 0.75
The impact of fragility fractures on health-related quality of life in patients with primary sclerosing cholangitis. Hepat Mon (2015) 0.75
A review of the medical treatment of primary sclerosing cholangitis in the 21st century. Ther Adv Chronic Dis (2016) 0.75
Newly Diagnosed Colonic Adenocarcinoma: The Presenting Sign in a Young Woman with Undiagnosed Crohn's Disease in the Absence of Primary Sclerosing Cholangitis and a Normal Microsatellite Instability Profile. Case Rep Pathol (2017) 0.75
Recurrence of autoimmune liver diseases after liver transplantation. World J Hepatol (2015) 0.75
A gentleman with anemia and cholestasis. Case Rep Med (2010) 0.75
Gut Inflammation in Primary Sclerosing Cholangitis and Autoimmune Sclerosing Cholangitis-Contrasting Pattern of Liver-gut Cross Talk. EBioMedicine (2015) 0.75
The 2016 diagnostic criteria for primary sclerosing cholangitis. J Gastroenterol (2016) 0.75
Evolving strategies to reduce colectomy rates in primary sclerosing cholangitis-inflammatory bowel disease: clinical remission of corticosteroid refractory colitis post-liver transplant with vedolizumab. Frontline Gastroenterol (2016) 0.75
Is ileal pouch-anal anastomosis after Whipple procedure doable? Tech Coloproctol (2016) 0.75
Epigenetics in the Primary Biliary Cholangitis and Primary Sclerosing Cholangitis. Semin Liver Dis (2017) 0.75
Th1 and Innate Lymphoid Cells accumulate in Primary Sclerosing Cholangitis-associated Inflammatory Bowel Disease. J Crohns Colitis (2017) 0.75
Management of ulcerative colitis pre- and post-liver transplant for primary sclerosing cholangitis: two case reports and review of literature. Int J Colorectal Dis (2014) 0.75
Primary sclerosing cholangitis: a review of its clinical features, cholangiography, and hepatic histology. Gut (1980) 4.09
Hepatic and extrahepatic malignancies in primary sclerosing cholangitis. J Hepatol (2002) 3.72
Clinicopathologic features of the syndrome of primary sclerosing cholangitis. Gastroenterology (1980) 3.57
Ursodeoxycholic acid as a chemopreventive agent in patients with ulcerative colitis and primary sclerosing cholangitis. Gastroenterology (2003) 3.22
Primary sclerosing cholangitis in ulcerative colitis--a risk factor for the development of dysplasia and DNA aneuploidy? Gastroenterology (1992) 2.61
Primary sclerosing cholangitis and ulcerative colitis: evidence for increased neoplastic potential. Hepatology (1995) 2.44
Current concepts. Primary sclerosing cholangitis. N Engl J Med (1984) 2.35
Ursodiol use is associated with lower prevalence of colonic neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis. Ann Intern Med (2001) 2.22
Risk and natural history of colonic neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis. Gastroenterology (1996) 1.82
Cholangiocarcinoma complicating primary sclerosing cholangitis. Ann Surg (1991) 1.78
Primary sclerosing cholangitis: a long-term follow-up study. Scand J Gastroenterol (1987) 1.73
Pericholangitis and sclerosing cholangitis are risk factors for dysplasia and cancer in ulcerative colitis. Am J Gastroenterol (1993) 1.70
Primary sclerosing cholangitis: findings on cholangiography and pancreatography. Radiology (1983) 1.49
Liver involvement in patients operated for ulcerative colitis, with special reference to the association of cholangitis with colorectal dysplasia and carcinoma. Int J Colorectal Dis (2000) 1.43
The risk for cancer or dysplasia in ulcerative colitis patients with primary sclerosing cholangitis. Am J Gastroenterol (1999) 1.40
Hepatobiliary carcinoma associated with primary sclerosing cholangitis and chronic ulcerative colitis. Hum Pathol (1985) 1.34
Risk of colorectal neoplasia in patients with primary sclerosing cholangitis. Gastroenterology (1996) 1.33
Risk factors of colorectal cancer in inflammatory bowel disease. Am J Gastroenterol (1996) 1.17
Relationship of inflammatory bowel disease and primary sclerosing cholangitis. Semin Liver Dis (1991) 1.15
Differences in colonic disease activity in patients with ulcerative colitis with and without primary sclerosing cholangitis: a case control study. Dis Colon Rectum (1997) 1.13
Proximal colorectal dysplasia or cancer in ulcerative colitis. The impact of primary sclerosing cholangitis and sulfasalazine: results from a 20-year surveillance study. Dis Colon Rectum (2001) 1.06
The risk of cancer and dysplasia among ulcerative colitis patients with primary sclerosing cholangitis. Am J Gastroenterol (1997) 1.00
Subclinical time span of inflammatory bowel disease in patients with primary sclerosing cholangitis. Dis Colon Rectum (1995) 0.96
Increased colorectal neoplasia in chronic ulcerative colitis complicated by primary sclerosing cholangitis: fact or fiction? Gut (2001) 0.95
Primary sclerosing cholangitis and colorectal carcinoma in patients with chronic ulcerative colitis: a case-control study. Cancer (1998) 0.95
Colorectal neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis. Dis Colon Rectum (1995) 0.91
Interactions between chronic liver disease and inflammatory bowel disease. Inflamm Bowel Dis (1997) 0.91
Forty-six patients with primary sclerosing cholangitis: radiological bile duct changes in relationship to clinical course and concomitant inflammatory bowel disease. Hepatogastroenterology (1988) 0.87
Colorectal dysplasia and carcinoma in patients with ulcerative colitis and primary sclerosing cholangitis. Scand J Gastroenterol (1997) 0.87
Controlled clinical trials: the controls are the key. Gastroenterology (1996) 0.86
Comparison of surgical treatment of ulcerative colitis associated with primary sclerosing cholangitis: ileal pouch-anal anastomosis versus Brooke ileostomy. Mayo Clin Proc (1996) 0.84
Relationship between colorectal neoplasia and primary sclerosing cholangitis in ulcerative colitis. Gastroenterology (1992) 0.83
Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota. Gastroenterology (1997) 8.51
Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study. N Engl J Med (1987) 7.73
A simple classification of Crohn's disease: report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998. Inflamm Bowel Dis (2000) 6.90
A clinical trial of a chest-pain observation unit for patients with unstable angina. Chest Pain Evaluation in the Emergency Room (CHEER) Investigators. N Engl J Med (1998) 5.67
Clinical Pharmacogenetics Implementation Consortium guidelines for thiopurine methyltransferase genotype and thiopurine dosing. Clin Pharmacol Ther (2011) 5.44
Dyspepsia and dyspepsia subgroups: a population-based study. Gastroenterology (1992) 4.84
Eosinophilic gastroenteritis: a clinicopathological study of patients with disease of the mucosa, muscle layer, and subserosal tissues. Gut (1990) 4.60
Simplified assessment of segmental colonic transit. Gastroenterology (1987) 4.59
Crohn's disease in Olmsted County, Minnesota, 1940-1993: incidence, prevalence, and survival. Gastroenterology (1998) 4.52
Increasing incidence of adenocarcinoma of the esophagus and esophagogastric junction. Gastroenterology (1993) 4.23
Surgical management of Meckel's diverticulum. An epidemiologic, population-based study. Ann Surg (1994) 4.16
Peptoids: a modular approach to drug discovery. Proc Natl Acad Sci U S A (1992) 4.08
A 21-year experience with major hemorrhage after percutaneous liver biopsy. Gastroenterology (1990) 4.02
Risk factors for prosthetic joint infection: case-control study. Clin Infect Dis (1998) 3.96
Epidemiology of colonic symptoms and the irritable bowel syndrome. Gastroenterology (1991) 3.90
Etanercept for active Crohn's disease: a randomized, double-blind, placebo-controlled trial. Gastroenterology (2001) 3.85
Prevalence of columnar-lined (Barrett's) esophagus. Comparison of population-based clinical and autopsy findings. Gastroenterology (1990) 3.77
The epidemiology and natural history of Crohn's disease in population-based patient cohorts from North America: a systematic review. Aliment Pharmacol Ther (2002) 3.71
The natural history of corticosteroid therapy for inflammatory bowel disease: a population-based study. Gastroenterology (2001) 3.60
A patient questionnaire to identify bowel disease. Ann Intern Med (1989) 3.43
Assessment of functional gastrointestinal disease: the bowel disease questionnaire. Mayo Clin Proc (1990) 3.34
Transdermal nicotine for mildly to moderately active ulcerative colitis. A randomized, double-blind, placebo-controlled trial. Ann Intern Med (1997) 3.29
Optimal testing parameters for blood cultures. Clin Infect Dis (2004) 3.17
A new questionnaire for gastroesophageal reflux disease. Mayo Clin Proc (1994) 3.14
Anterior temporal lobes and hippocampal formations: normative volumetric measurements from MR images in young adults. Radiology (1989) 3.12
Lack of discriminant value of dyspepsia subgroups in patients referred for upper endoscopy. Gastroenterology (1993) 2.99
Hereditary angioedema: a broad review for clinicians. Arch Intern Med (2001) 2.92
Risk factors for irritable bowel syndrome: role of analgesics and food sensitivities. Am J Gastroenterol (2000) 2.89
Ulcerative colitis in Olmsted County, Minnesota, 1940-1993: incidence, prevalence, and survival. Gut (2000) 2.86
Medical costs in community subjects with irritable bowel syndrome. Gastroenterology (1995) 2.81
Infliximab in the treatment of severe, steroid-refractory ulcerative colitis: a pilot study. Inflamm Bowel Dis (2001) 2.80
Risk factors associated with symptoms of gastroesophageal reflux. Am J Med (1999) 2.75
Comparison of LightCycler PCR, rapid antigen immunoassay, and culture for detection of group A streptococci from throat swabs. J Clin Microbiol (2003) 2.57
A prospective randomized comparison of laparoscopic appendectomy with open appendectomy: Clinical and economic analyses. Surgery (2001) 2.57
Temporal lobe seizures: lateralization with MR volume measurements of the hippocampal formation. Radiology (1990) 2.56
Onset and disappearance of gastrointestinal symptoms and functional gastrointestinal disorders. Am J Epidemiol (1992) 2.54
Gastric adenocarcinoma and Helicobacter pylori infection. J Natl Cancer Inst (1991) 2.35
Sex differences in evaluation and outcome of unstable angina. JAMA (2000) 2.33
A comparison of the Rome and Manning criteria for case identification in epidemiological investigations of irritable bowel syndrome. Am J Gastroenterol (2000) 2.27
Quality of colonoscopy performance among gastroenterology and surgical trainees: a need for common training standards for all trainees? Endoscopy (2011) 2.25
Randomised clinical trial: deep remission in biologic and immunomodulator naïve patients with Crohn's disease - a SONIC post hoc analysis. Aliment Pharmacol Ther (2015) 2.25
Pouchitis after ileal pouch-anal anastomosis: a Pouchitis Disease Activity Index. Mayo Clin Proc (1994) 2.23
Fine-needle aspiration biopsy of thyroid nodules. Impact on thyroid practice and cost of care. Am J Med (1982) 2.23
Randomised clinical trial: herbal extract HMPL-004 in active ulcerative colitis - a double-blind comparison with sustained release mesalazine. Aliment Pharmacol Ther (2010) 2.20
Adalimumab for the treatment of fistulas in patients with Crohn's disease. Gut (2009) 2.20
CT colonography without cathartic preparation: feasibility study. Radiology (2001) 2.19
A prospective cohort study to determine the relationship between serum infliximab concentration and efficacy in patients with luminal Crohn's disease. Aliment Pharmacol Ther (2014) 2.18
Prevalence of gastrointestinal symptoms in the elderly: a population-based study. Gastroenterology (1992) 2.17
Balsalazide and azathiprine or 6-mercaptopurine: evidence for a potentially serious drug interaction. Gastroenterology (1999) 2.14
Hepatic resection for metastatic colorectal cancer results in cure for some patients. Arch Surg (1997) 2.13
Effect of colesevelam on faecal bile acids and bowel functions in diarrhoea-predominant irritable bowel syndrome. Aliment Pharmacol Ther (2015) 2.13
Gastrointestinal tract symptoms and self-reported abuse: a population-based study. Gastroenterology (1994) 2.12
Validating biomarkers of treatable mechanisms in irritable bowel syndrome. Neurogastroenterol Motil (2014) 2.11
Relation among personality and symptoms in nonulcer dyspepsia and the irritable bowel syndrome. Gastroenterology (1990) 2.09
Severe exercise-induced ischemia does not identify high risk patients with normal left ventricular function and one- or two-vessel coronary artery disease. J Am Coll Cardiol (1994) 2.08
Clinical predictors of recurrent Clostridium difficile infection in out-patients. Aliment Pharmacol Ther (2014) 2.08
Secular trends in the epidemiology and outcome of Barrett's oesophagus in Olmsted County, Minnesota. Gut (2001) 2.05
Mycophenolate mofetil for Crohn's disease? Lancet (1999) 2.03
Constipation in an elderly community: a study of prevalence and potential risk factors. Am J Gastroenterol (1996) 2.01
Self-reported abuse and gastrointestinal disease in outpatients: association with irritable bowel-type symptoms. Am J Gastroenterol (1995) 1.99
Clinical pharmacogenetics implementation consortium guidelines for thiopurine methyltransferase genotype and thiopurine dosing: 2013 update. Clin Pharmacol Ther (2013) 1.99
Intentional infliximab use during pregnancy for induction or maintenance of remission in Crohn's disease. Aliment Pharmacol Ther (2005) 1.96
Irritable bowel syndrome in a community: symptom subgroups, risk factors, and health care utilization. Am J Epidemiol (1995) 1.94
Predictors of outcome after percutaneous endoscopic gastrostomy: a community-based study. Mayo Clin Proc (1992) 1.94
Lipoprotein analysis in the evaluation of chest pain in the emergency department. Mayo Clin Proc (1991) 1.92
Effects of an irritable bowel syndrome educational class on health-promoting behaviors and symptoms. Am J Gastroenterol (1998) 1.88
A randomized controlled trial of a probiotic, VSL#3, on gut transit and symptoms in diarrhoea-predominant irritable bowel syndrome. Aliment Pharmacol Ther (2003) 1.85
Lack of effect of intravenous administration on time to respond to azathioprine for steroid-treated Crohn's disease. North American Azathioprine Study Group. Gastroenterology (1999) 1.84
MR imaging-based volume measurements of the hippocampal formation and anterior temporal lobe: validation studies. Radiology (1990) 1.84
Epidemiologic aspects of Crohn's disease: a population based study in Olmsted County, Minnesota, 1943-1982. Gut (1988) 1.82
Nonsteroidal antiinflammatory drugs and dyspepsia in the elderly. Dig Dis Sci (1995) 1.81
Clinical comparison of BACTEC 9240 plus aerobic/F resin bottles and the isolator aerobic culture system for detection of bloodstream infections. J Clin Microbiol (1997) 1.81
Relation between antral motility and gastric emptying of solids and liquids in humans. Am J Physiol (1985) 1.81
Misdiagnosis of specific cytomegalovirus infection of the ileoanal pouch as refractory idiopathic chronic pouchitis: report of two cases. Dis Colon Rectum (1999) 1.79
Quality of life after proctocolectomy. A comparison of Brooke ileostomy, Kock pouch, and ileal pouch-anal anastomosis. Gastroenterology (1991) 1.77
Towards a less costly but accurate test of gastric emptying and small bowel transit. Dig Dis Sci (1991) 1.76
Randomised trial of once- or twice-daily MMX mesalazine for maintenance of remission in ulcerative colitis. Gut (2008) 1.75
Functional constipation and outlet delay: a population-based study. Gastroenterology (1993) 1.74
Human gastric emptying and colonic filling of solids characterized by a new method. Am J Physiol (1989) 1.73
Performance characteristics of scintigraphic colon transit measurement in health and irritable bowel syndrome and relationship to bowel functions. Neurogastroenterol Motil (2009) 1.73
Optimization of CT colonography technique: prospective trial in 180 patients. Radiology (2000) 1.72
Risk of lymphoma in inflammatory bowel disease. Am J Gastroenterol (2000) 1.71
Increasing incidence of pancreatic cancer among women in Olmsted County, Minnesota, 1940 through 1988. Mayo Clin Proc (1992) 1.69